Your browser doesn't support javascript.
loading
Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia.
Baron, Elodie; Charpentier, Julien; François, Anne; Ben Hadj Amor, Habib; Habr, Bassem; Cariou, Alain; Chiche, Jean-Daniel; Mira, Jean-Paul; Jamme, Matthieu; Pène, Frédéric.
Afiliación
  • Baron E; Médecine intensive & Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris-Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Charpentier J; Médecine intensive & Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris-Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • François A; Etablissement Français du Sang, Paris, France.
  • Ben Hadj Amor H; Etablissement Français du Sang, Paris, France.
  • Habr B; Université Saint-Joseph, Beirut, Lebanon.
  • Cariou A; Médecine intensive & Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris-Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Chiche JD; Université Paris Descartes, Paris, France.
  • Mira JP; Médecine intensive & Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris-Centre, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Jamme M; Université Paris Descartes, Paris, France.
  • Pène F; Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.
Transfusion ; 60(2): 275-284, 2020 02.
Article en En | MEDLINE | ID: mdl-31724828
BACKGROUND: Platelet transfusion is aimed at increasing platelet counts to prevent or treat bleeding. Critically ill cancer patients with hypoproliferative thrombocytopenia are high consumers of blood products. We herein described their post-transfusion platelet responses in the intensive care unit (ICU) and analyzed the determinants of poor post-transfusion increments. STUDY DESIGN AND METHODS: This was a single-center 9-year (2009-2017) retrospective observational study. Patients with malignancies and presumed or proven hypoproliferative thrombocytopenia who had received at least one platelet transfusion in the ICU were included. Poor post-transfusion platelet increments were defined as body surface-adjusted corrected count increment (CCI) <7, or alternatively as weight-adjusted platelet transfusion recovery (PTR) <0.2. Patients were deemed refractory to platelet transfusions when two consecutive ABO-compatible transfusions resulted in poor platelet increments. RESULTS: A total of 1470 platelet transfusions received by 326 patients were analyzed. Indications for platelet transfusions were distributed into prophylactic (44.5%), peri-procedural (18.1%) and therapeutic (37.4%). Regardless of indications, 54.6% and 55.4% of transfusion episodes were associated with a CCI <7 or a PTR <0.2. Factors independently associated with poor post-transfusion increments were lower body mass index, spleen enlargement, concurrent severity of clinical condition, fever ≥39°C, antibiotic therapy and increased storage duration of platelet concentrates. Eventually, 48 patients developed refractoriness to platelet transfusion, which was associated increased incidence of bleeding events. CONCLUSION: Platelet transfusions are often associated with poor increments in critically ill cancer patients with hypoproliferative thrombocytopenia. The findings suggest amenable interventions to improve the platelet transfusion practices in this setting.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Enfermedad Crítica / Transfusión de Plaquetas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Enfermedad Crítica / Transfusión de Plaquetas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2020 Tipo del documento: Article País de afiliación: Francia